Patients with moderately severe intracerebral hemorrhage (ICH) who receive intracranial pressure (ICP) monitoring and management have a reduced risk of mortality at 6 months compared with patients who do not receive this mode of therapy.
Why this matters?
Although ICH accounts for a small proportion of stroke cases, it is the third leading cause of stroke-related morbidity and mortality.
While guideline recommendations include ICP management and monitoring, specific advice on how to optimally perform these are unknown.
Findings from this study highlight the need to develop standardized practice recommendations for the management of ICH by treating and monitoring ICP.